- LLY -2.77%
Search results
- 734.97Add to watchlist-20.94 (-2.77%)At close: Fri. May 3, 2024 4:00 PM EDT · Nasdaq Real Time Price (USD) · Market closed
- Open743.00High745.00Low730.34
- Mkt Cap698.52BP/E (TTM)108.72Div & Yield5.20 & 0.71%
- Prev. Close755.9152 Wk. Low419.8052 Wk. High800.78
What analysts are sayingTop storiesEli Lilly and Company (NYSE:LLY) Q1 2024 Earnings Call TranscriptYahoo Finance · 2 days ago- LLY -2.77%
Decoding Eli Lilly and Co (LLY): A Strategic SWOT InsightYahoo Finance · 4 days ago- LLY -2.77%
Eli Lilly and Company (NYSE:LLY) Just Released Its First-Quarter Earnings: Here's What Analysts ThinkYahoo Finance · 3 days agoRelated stocks
View the latest Eli Lilly & Co. (LLY) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Discover real-time Eli Lilly and Company Common Stock (LLY) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.
MT Newswires • 9 hours ago. LLY. -0.56% NVO. +0.70% ETFs to Buy as Eli Lilly Beats Q1 Earnings, Lifts Outlook. Eli Lilly and Company (LLY) raised its outlook for 2024 on rapidly climbing sales...
View Eli Lilly and Company LLY stock quote prices, financial information, real-time forecasts, and company news from CNN.
5 days ago · Momentum. Peers. Options. Charting. 52 Week Range. 414.31 800.78. Day Range. 767.66 795.50. EPS (FWD) 12.46. PE (FWD) 59.17. Div Rate (FWD) $5.20. Yield (FWD) 0.67% Market Cap. $703.59B. Volume....
LLY:US. New York (USD) · Market closed. 755.91. –20.84 –2.68% As of 12:00 AM EDT 05/02/24. Prev. close. 776.75 USD. 756.30 USD. 3:58 PM. 9:30a 10:25a 11:20a 12:16p 1:11p 2:07p 3:02p 3:58p 754.47...
Eli Lilly and Company is a leading global pharmaceutical company that develops and markets innovative medicines for various health conditions. On its stock quote and chart page, you can find the latest information on its share price, performance, dividends, and historical data. You can also learn more about its recent acquisitions, new drug approvals, and career opportunities in different ...